Natural Capsules Ltd

BSE: 524654

total announcements

NATCAPSUQ.BO · 15 min delayed

Key Stats · Yahoo Finance · as of 31 Oct 2026

Market Cap

₹142 Cr

P/E (Forward)

11.1

EPS (TTM)

₹-24.01

52W Low

₹134.00

52W High

₹237.00

Dividend Yield

0.00%

Beta

0.01

Price / Book

0.6

Debt / Equity

49.2

Revenue (TTM)

₹191 Cr

Gross Margin

42.96%

Operating Margin

-6.59%

Announcements Discussion

BSEBoard MeetingResults4 Aug 2026

Natural Capsules Ltd

Natural Capsules Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 ,inter alia, to consider and approve 1. To Consider and approve ....

Natural Capsules Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 to consider and approve the unaudited consolidated & standalone financial results of the Company for the quarter ended June 30th, 2026.

Natural Biogenex Private Limited ("Material Unlisted Subsidiary"), at its Board Meeting held on today, i.e. July 31, 2026, has approved the Allotment of the Right Issue duly approved on ....

Natural Capsules Ltd's material unlisted subsidiary, Natural Biogenex Private Limited, has approved the allotment of 946,305 equity shares for a cash consideration of ₹94,63,050.

Board of Director of the Company has inter-alia considered and approved a Resolution Passed by Circulation on 28th July, 2026 and the final majority vote was received by 08:00 PM decided ....

Natural Capsules Ltd has informed the BSE and NSE that its Board of Directors has approved a resolution to not participate in the Rights Issue offered by its subsidiary company, Natural Biogenex Private Limited, resulting in a dilution of 2.18% of the company's equity stake in the subsidiary.